The Current Ratio as of September 2024 (TTM) for Brii Biosciences Limited (BRIBF) is 22.11

According to Brii Biosciences Limited’s latest financial reports and current stock price. The company's current Current Ratio is 22.11. This represents a change of 26.80% compared to the average of 17.44 of the last 4 quarters.

Brii Biosciences Limited (BRIBF) Historical Current Ratio (quarterly & annually)

How has BRIBF Current Ratio performed in the past?

The mean historical Current Ratio of Brii Biosciences Limited over the last ten years is 12.78. The current 22.11 Current Ratio has changed 17.20% with respect to the historical average. Over the past ten years (40 quarters), BRIBF's Current Ratio was at its highest in in the March 2023 quarter at 25.53. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Brii Biosciences Limited (BRIBF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Brii Biosciences Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Brii Biosciences Limited (BRIBF) Average Current Ratio

How has BRIBF Current Ratio performed in the past?

The current Current Ratio of Brii Biosciences Limited (BRIBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Brii Biosciences Limited (BRIBF) Current Ratio vs. Peers

How is BRIBF’s Current Ratio compared to its peers?

Brii Biosciences Limited’s Current Ratio is greater than Avalo Therapeutics, Inc. (0.99), greater than Alzamend Neuro, Inc. (0.49), less than Virax Biolabs Group Limited (25.94), greater than Kiromic BioPharma, Inc. (0.35), greater than Benitec Biopharma Inc. (4.18), greater than Cardio Diagnostics Holdings, Inc. (5.69), greater than Sigilon Therapeutics, Inc. (1.78), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than ZyVersa Therapeutics, Inc. (0.06), greater than X4 Pharmaceuticals, Inc. (6.07), greater than Terns Pharmaceuticals, Inc. (21.02), greater than 89bio, Inc. (13.92), greater than Cabaletta Bio, Inc. (11.52), less than Akero Therapeutics, Inc. (24.89), greater than Mirum Pharmaceuticals, Inc. (3.28), greater than Inozyme Pharma, Inc. (9.84), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than HOOKIPA Pharma Inc. (3.86), greater than Axsome Therapeutics, Inc. (2.48), greater than Incyte Corporation (1.92), greater than ImmunoGen, Inc. (5.47), greater than Sarepta Therapeutics, Inc. (3.90), greater than ACADIA Pharmaceuticals Inc. (2.16),

Build a custom stock screener for Brii Biosciences Limited (BRIBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brii Biosciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Brii Biosciences Limited (BRIBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Brii Biosciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.